AnilGulatiMDPhD

Summary

• Anil Gulati, MD, PhD is Professor Emeritus at Midwestern University, the University of Illinois at Chicago, and is a consultant to Advocate Lutheran General Children's Hospital. He is the Chairman and Chief Executive Officer at Pharmazz, Inc., Willowbrook, Illinois. Dr. Gulati is leading clinical development and commercialization of first-in-class drug products in critical care medicine. He has led the research, invented, developed, and obtained marketing authorization of a first-in-class resuscitative agent indicated for patients with hypovolemic shock as a frontline adjuvant to the standard of care. His main focus is the discovery of drugs to treat cerebral stroke, Alzheimer's disease, and resuscitative agents for shock. He has 54 issued patents. He is a recipient of the Outstanding Faculty Award 2017, Paul R Dawson Biotechnology Award 2014, and the distinguished Littlejohn Award 2014. Dr. Gulati is not only a United States Fulbright Scholar 2008-2009, but he is also a winner of the International Ranbaxy Research Award 2007. Dr. Gulati was the Scientific Reviewer of the United States Defense Medical Research and Development Program, Combat Casualty Care Research Program 2016 and 2017. As the Professor and Associate Dean of Research, he promoted the medical research and faculty development of more than 50 faculty members. In addition, Dr. Gulati trained hundreds of medical residents and fellows to be research-oriented physicians and guided researches for more than 100 graduate students. He has ~300 peer-reviewed publications, 6,280 citations, an h-index of 43, an i10-index of 165, Research Gate score of 47.29. Dr. Gulati continues to forge ahead with discovering and developing new therapies for critically ill patients and his contributions to education and research.